Yes you will see near-term PPS adjustments that will correlate with market conditions & current price offering, however look at the big picture as we near completion of FDA approval for Ampion and the earnings call in a few weeks, CEO should provide more color on current situation. Plus, at the end of the day in 3 months, they should have $26M + lets say $70M from recent shelf offering, close to $100M minus quarterly operating costs, still hovering around $80M in the bank before BLA docs submitted for approval. At least they can get financing. And having capital on hand has always been a major factor. Lets say this gets approved, they look good on paper. Its all speculation, but I would anticipate interest going in the 1st week of March and it should bounce back. Just a thought. Good luck.
Think of it this way - some very smart people bought a total of over 1.2 MILLION shares today! It will be a successful offering and price will jump just because fear subsides. Look at what happened after the last offering! And that was a SMALL one.